Investigator

Tao Jiang

Southwest Medical University, opreation room

TJTao Jiang
Papers(2)
Operating-room temper…SULF2 promotes tumori…
Collaborators(3)
Zhao-Hui ChenZhe ChenDan Tan
Institutions(3)
Southwest Medical Uni…Linzhou Cancer Hospit…First Peoples Hospita…

Papers

Operating-room temperature and warming protocols as predictors of postoperative hypothermia in ovarian cancer surgery: A retrospective cohort study

Perioperative hypothermia is a common but preventable complication associated with increased morbidity and delayed recovery in surgical oncology patients. However, limited evidence exists regarding its prevalence, predictors, and consequences in women undergoing cytoreductive surgery for ovarian cancer. This retrospective cohort study included 245 patients who underwent primary or interval cytoreductive surgery for epithelial ovarian cancer at a tertiary care center between 2014 and 2022. Patients were stratified into normothermia (≥36.0°C) and hypothermia (<36.0°C) groups based on core temperature at surgical closure. Intraoperative warming strategies and operating-room temperature were recorded. Multivariate logistic regression was used to identify independent predictors of postoperative hypothermia. Postoperative outcomes were compared between groups. Postoperative hypothermia occurred in 39.6% of patients. Independent risk factors included age ≥ 60 years (odds ratio [OR] 1.89, P  = .025), body mass index < 22 kg/m² (OR 1.96, P  = .022), American Society of Anesthesiologists class III–IV (OR 2.05, P  = .020), ascites volume > 500 mL (OR 1.97, P  = .031), operative time ≥ 240 minutes (OR 2.92, P  = .001), blood loss ≥ 400 mL (OR 2.23, P  = .011), absence of active warming (OR 4.12, P  < .001), and OR temperature < 22°C (OR 2.47, P  = .005). Hypothermia was associated with higher rates of shivering (40.2% vs 12.2%, P  < .001), surgical site infection (16.5% vs 6.8%, P  = .019), longer time to ambulation and gastrointestinal recovery, prolonged hospital stay, and increased 30-day readmission. Postoperative hypothermia is highly prevalent and clinically significant among ovarian cancer patients undergoing cytoreductive surgery. Intraoperative warming strategies and maintaining adequate OR temperatures play critical roles in prevention. These findings highlight the importance of standardized thermal care protocols led by perioperative nursing teams to improve surgical outcomes. These conclusions apply to female patients only, as the cohort exclusively comprised women undergoing ovarian cancer cytoreductive surgery.

SULF2 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells through the ERK/AKT signaling pathway

The objective of this study was to explore the role of the SULF2-mediated ERK/AKT signaling pathway in cervical cancer. SULF2 expression was detected in tumor tissues and tumor-adjacent normal tissues from cervical cancer patients. HeLa cells were divided into six groups: control group, NC group, SULF2 siRNA group, SULF2 group, SULF2 + LY294002 group, and SULF2 + U0125 group. In each group, HeLa cells received the corresponding treatment, followed by measurement of the cellular biological characteristics and expression of the ERK/AKT signaling pathway. We also confirmed the effect of SULF2 in vivo using a xenograft model in nude mice. SULF2 was upregulated in cervical cancer tissues, which was specifically associated with the clinical stage, histological differentiation, and lymphatic metastasis. Compared to the control group, the SULF2 siRNA group displayed decreased expression of SULF2, concomitant with reduced proliferation, migration, and invasion, but there was an increase in the apoptosis rate of HeLa cells, as well as downregulation of the p-Akt/Akt, p-ERK/ERK, and Bax/Bcl-2 ratios and cyclin D1. Additionally, tumor growth was significantly inhibited in the xenograft model of nude mice. The results in the SULF2 group were quite the opposite in which SULF2 facilitated the growth of cervical cancer cells, which was reversed by LY294002 or U0126. SULF2 is highly expressed in cervical cancer, and thus, downregulation of SULF2 can inhibit the ERK1/2 and AKT signaling pathways to suppress the proliferation, invasion, and migration of cervical cancer cells while facilitating apoptosis.

2Papers
3Collaborators
Ovarian Neoplasms

Positions

Researcher

Southwest Medical University · opreation room